研究目的
The goal of this research was to evaluate the effects of intradermic laser irradiation on blood (ILIB) to relieve pain and improve the quality of life in diabetic neuropathy (DN) patients.
研究成果
This study demonstrated that ILIB therapy was effective in reducing pain and improving quality of life in patients with DN. The results suggest that ILIB could be a relevant therapeutic option for DN, offering noninvasive treatment with no side effects.
研究不足
The study was limited to a small sample size of 30 volunteers and did not explore the long-term effects of ILIB therapy beyond the study period. Additionally, the study did not investigate the mechanisms underlying the observed effects of ILIB in detail.
1:Experimental Design and Method Selection:
The study was a clinical, controlled, randomized, prospective, interventional, and qualitative/quantitative study. It evaluated the effects of ILIB in relieving pain and improving the quality of life in DN patients.
2:Sample Selection and Data Sources:
The sample consisted of 30 diabetic volunteers with DN, randomly assigned to three groups: control, SILIB, and ILIB.
3:List of Experimental Equipment and Materials:
A therapeutic laser in the red electromagnetic spectrum (100-mW power and 660 – 10 nm wavelength) was used for ILIB applications.
4:Experimental Procedures and Operational Workflow:
The ILIB group underwent active ILIB applications associated with conventional treatment, while the SILIB group underwent a simulation of ILIB applications with the device switched off. The control group received conventional treatment only.
5:Data Analysis Methods:
Data were analyzed using the GraphPad Prism program, v. 5, with a Kolmogorov–Smirnov normality test, Wilcoxon’s nonparametric test for intragroup comparison, and the Kruskal–Wallis test with Dunn’s post-test for intergroup evaluation.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容